Angiogenesis Inhibitors in the Treatment of Breast Cancer: Exploring Avenues of New Therapeutic Targets

@inproceedings{Patel2015AngiogenesisII,
  title={Angiogenesis Inhibitors in the Treatment of Breast Cancer: Exploring Avenues of New Therapeutic Targets},
  author={Ayesha M Patel and Abigail Hielscher},
  year={2015}
}
Angiogenesis is the physiological process through which new blood vessels form from pre-existing blood vessels and it is a critical part of development and wound healing [1]. This vascular network can originate in three ways: new blood vessels can sprout from existing vessels; new vessels can arise from bone marrow derived endothelial progenitor cells; or capillary walls can invaginate into their lumen and cause existing vessels to split into two new vessels [1]. In order for any of these… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 54 REFERENCES

Anti-Vascular Endothelial Growth Factor Therapy in Breast Cancer

  • International journal of molecular sciences
  • 2014
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

MicroRNA-542-3p inhibits tumour angiogenesis by targeting angiopoietin-2.

  • The Journal of pathology
  • 2014
VIEW 9 EXCERPTS
HIGHLY INFLUENTIAL

Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties

F Bono, F De Smet, C Herbert, K De Bock, M Georgiadou
  • Cancer Cell
  • 2013
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells.

  • Proceedings of the National Academy of Sciences of the United States of America
  • 2012
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…